Incidence of Rifampicin Resistance in Periprosthetic Joint Infection: A Single-Centre Cohort Study on 238 Patients
Background. Rifampicin is a pillar in the treatment of periprosthetic joint infection (PJI). However, rifampicin resistance is an increasing threat to PJI treatment. This study explores the incidence of rifampicin-resistant bacteria over time in a Swedish tertiary referral centre and the association...
Saved in:
Main Authors: | Stergios Lazarinis (Author), Nils P. Hailer (Author), Josef D. Järhult (Author), Anders Brüggemann (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early Staphylococcal Periprosthetic Joint Infection (PJI) Treated with Debridement, Antibiotics, and Implant Retention (DAIR): Inferior Outcomes in Patients with Staphylococci Resistant to Rifampicin
by: Hannah K. Eriksson, et al.
Published: (2023) -
Candida Periprosthetic Joint Infection: Is It Curable?
by: Laura Escolà-Vergé, et al.
Published: (2021) -
The diagnosis of periprosthetic joint infection after the arthroplasty of knee joint
by: Hanna Tsitko, et al.
Published: (2022) -
Do High Doses of Multiple Antibiotics Loaded into Bone Cement Spacers Improve the Success Rate in Staphylococcal Periprosthetic Joint Infection When Rifampicin Cannot Be Employed?
by: Lourdes Prats-Peinado, et al.
Published: (2024) -
Potential Blood Biomarkers for Diagnosing Periprosthetic Joint Infection: A Single-Center, Retrospective Study
by: Hong Xu, et al.
Published: (2022)